|
|
|
|
| A ballooning clinical-stage ADC development community is putting stress on both manufacturing capacity and antibody engineering and conjugation talent. What does this burgeon mean for ADC manufacturing, process development, and, ultimately, clinical progress? Join Bioprocess Online Live on July 9th as we navigate the complexity of the ADC manufacturing environment. From linkers to payloads to conjugation, we’ll cover the lay of the land for developers. Registration is free thanks to the support of Cytiva. |
|
|
|
|
By Business of Biotech | According to KSQ’s Thomas Leitch, when it comes to selecting a manufacturing partner, company culture is as important as technological capabilities. |
|
|
| 4 Questions To Ask Your Fill/Finish Partner | Article | By Ramon Gonzalez, Ajinomoto Bio-Pharma Services | Reducing risk while maximizing API volume is critical during the fill finish phase of biopharmaceutical manufacturing. To ensure safety and quality, partner with an experienced fill finish provider. |
|
|
| Developing Robust mRNA Processes In A cGMP Environment | Poster | By Clemens Jakobi, Michal Domański, and Telmo Graça, Lonza | Explore current and emerging technologies to optimize mRNA manufacturing, especially when considering commercial production and the validation of processes in a cGMP environment. |
|
|
|
|
| Lentiviral Vector Platform: Right The First Time | Article | By Mercedes Segura, Dawn Maier, and Bojiao Yin, ElevateBio | Leveraging the right LVV manufacturing platform can accelerate timelines, better manage costs, and transform product development and potential for clinical success so that therapies reach patients in need. |
|
|
|
|
|
|
|
| Complex protein-based therapies don’t play by the same process-engineering rules as small molecules and traditional biologics. They require developers to see the unforeseen and embrace new roles and responsibilities in sourcing raw materials and outsourced expertise. Successful developers can’t let this winding road slow their time to IND. Join Bioprocess Online Live on August 8th for an interactive discussion on early workflow considerations for complex protein-based therapeutics. Supported by Thermo Fisher Scientific. |
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
